The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $433,138 in first-year total cost, median $216,569.
Most frequent study sections
- Special Emphasis Panel[ZRG1 OBT-B (55)]1
- Special Emphasis Panel[ZRG1 OBT-S (55)]1
Most frequent institutions
- FRED HUTCHINSON CANCER RESEARCH CENTER1
- UNIVERSITY OF ILLINOIS AT CHICAGO1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2019 | Targeting Microtubule Associated Protein Tau in Ovarian Carcinoma to Increase Efficacy of Paclitaxel1R21CA235530-01A1 | BARBOLINA, MARIA V. | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | $203,458 | ZRG1 |
| 2018 | Critical role for a TrkB splice variant in oncogenic signaling1R21CA223531-01A1 | HOLLAND, ERIC C. | FRED HUTCHINSON CANCER RESEARCH CENTER, WA | $229,680 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.